| Highlights | Board of directors | Senior management |
A proven management team.
The ARIAD management team is the right mix of talent, expertise and experience to lead our company as we build a leading integrated cancer company. In addition to people with proven scientific backgrounds, our team includes seasoned individuals who know how to build and run a business.
Executive Leadership Team
| Harvey J. Berger, M.D. | Chairman and Chief Executive Officer |
| David Berstein, Esq. | Senior Vice President and Chief Intellectual Property Officer |
| Daniel M. Bollag, Ph.D. | Senior Vice President of Regulatory Affairs and Quality |
| Maria E. Cantor | Vice President, Corporate Communications and Investor Relations |
| Timothy P. Clackson, Ph.D. | Senior Vice President and Chief Scientific Officer |
| Virginia R. Dean | Vice President, Human Resources |
| Pierre F. Dodion, M.D. | Senior Vice President and Chief Medical Officer |
| Edward M. Fitzgerald | Senior Vice President, Chief Financial Officer and Treasurer |
| John D. Iuliucci, Ph.D. | Senior Vice President, Development |
| Raymond T. Keane, Esq. | Senior Vice President, General Counsel, Secretary and Chief Compliance Officer |
| Matthew E. Ros | Senior Vice President, Commercial Operations |
Senior Management
| Joseph Bratica | Vice President, Finance and Controller |
| David C. Dalgarno, Ph.D. | Vice President, Research Technologies |
| Frank G. Haluska, M.D., Ph.D. | Vice President, Clinical Affairs |
| Shirish Hirani, Ph.D. | Vice President, Program and Alliance Management |
| John W. Loewy, Ph.D. | Vice President, Biostatistics and Outcomes Research |
| Ross D. Pettit | Vice President, Clinical Operations |
| Victor M. Rivera, Ph.D. | Vice President, Preclinical and Translational Research |
| Kelly M. Schmitz | Vice President, Information Technology and Operations |
| William C. Shakespeare, Ph.D. | Vice President, Drug Discovery |
| Andreas Woppmann, Ph.D. | Vice President, Manufacturing Operations |
